Senti Biosciences, Inc.

SNTINasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$22,000

Net Income

-$61.4M

▼ 16.4% YoY

EPS

$-2.73

▲ 77.3% YoY

Cash

$16.4M

▼ 66.0% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.